Solara Active Pharma Sciences Reports Strong Financial Performance in Q2 FY25
Solara Active Pharma Sciences, a smallcap pharmaceutical company, has recently announced its financial results for the quarter ending September 2024. The company has shown positive growth in its financial performance, with a score of 11 out of 100, compared to 0 in the previous quarter.
One of the key highlights of the financial results is the significant growth in Profit Before Tax (PBT) and Profit After Tax (PAT). PBT has grown by 110.7% to Rs 7.69 crore, while PAT has grown by 108.6% to Rs 8.01 crore, compared to the average of the previous four quarters. This indicates a very positive trend in the near term for the company.
Solara Active has also shown improvement in its ability to manage interest payments, with the Operating Profit to Interest ratio being the highest in the last five quarters. The company’s Operating Profit (PBDIT) has also been the highest at Rs 61.31 crore in the last five quarters, indicating a positive trend in the near term.
The company’s efficiency has also improved, with the Operating Profit Margin being the highest at 17.67% in the last five quarters. This shows that Solara Active is able to generate higher profits from its operations.
In terms of earnings, Solara Active has shown a positive trend with the highest Earnings per Share (EPS) of Rs 1.99 in the last five quarters. This indicates that the company has been able to create higher earnings for its shareholders.
However, one area of concern for Solara Active is the rising interest cost, which has grown by 20.72% in the preceding nine months period. This signifies increased borrowings by the company.
In conclusion, Solara Active Pharma Sciences has shown a positive financial performance in the quarter ending September 2024. With improving profitability and efficiency, the company is on a positive trajectory in the near term. However, investors should keep an eye on the rising interest cost. MarketsMOJO has given a ‘Sell’ call for the company’s stock.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
